EUVIMEDEUVIMED entdecken
Open Access

Susceptible bacteria can survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance

Marinelle Rodrigues, Parastoo Sabaeifard, Muhammed Sadik Yildiz, Adam Lyon, Laura Coughlin, Sara Ahmed, Nicole Poulides, Ahmet C Toprak, Cassie Behrendt, Xiaoyu Wang, Marguerite Monogue, Jiwoong Kim und 7 weitere

Cell Host & Microbe · 2024-03 · 32 (3) · 396-410.e6

DOI: 10.1016/j.chom.2024.01.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2024-03. Verfasst von Marinelle Rodrigues und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic resistance and evasion are incompletely understood and complicated by the fact that murine interval dosing models do not fully recapitulate antibiotic pharmacokinetics in humans. To better understand how gastrointestinal bacteria respond to antibiotics, we colonized germ-free mice with a pan-susceptible genetically barcoded Escherichia coli clinical isolate and administered the antibiotic cefepime via programmable subcutaneous pumps, allowing closer emulation of human parenteral antibiotic dynamics. E. coli was only recovered from intestinal tissue, where cefepime concentrations were still inhibitory. Strikingly, "some" E. coli isolates were not cefepime resistant but acquired mutations in genes involved in polysaccharide capsular synthesis increasing their invasion and survival within human intestinal cells. Deleting wbaP involved in capsular polysaccharide synthesis mimicked this phenotype, allowing increased invasion of colonocytes where cefepime concentrations were reduced. Additionally, "some" mutant strains exhibited a persister phenotype upon further cefepime exposure. This work uncovers a mechanism allowing "select" gastrointestinal bacteria to evade antibiotic treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliAnti-Bacterial AgentsHumansAnimalsMiceCefepimeBacteriaGastrointestinal TractPolysaccharidesMicrobial Sensitivity TestsMammals

Stichwörter der Autor:innen

Escherichia coliantibiotic persistenceantibiotic resistanceantibiotic tolerancebacterial survivalbacterial virulancemammalian GI tract

Substanzen

CefepimeAnti-Bacterial AgentsPolysaccharides

Autor:innen und Institutionen

  • Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Pediatrics, Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Pharmacy, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Internal Medicine, Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical…
  • Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • Howard Hughes Medical Institute
  • NIH
  • DOD
  • Human Frontier Science Program
  • Novartis

Zitieren

APA

Rodrigues, M., Sabaeifard, P., Yildiz, M. S., Lyon, A., Coughlin, L., Ahmed, S., Poulides, N., Toprak, A. C., Behrendt, C., Wang, X., Monogue, M., Kim, J., Gan, S., Zhan, X., Filkins, L., Williams, N. S., Hooper, L. V., Koh, A. Y., & Toprak, E. (2024). Susceptible bacteria can survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance. Cell Host & Microbe, 32(3), 396-410.e6. https://doi.org/10.1016/j.chom.2024.01.012

Vancouver

Rodrigues M, Sabaeifard P, Yildiz MS, Lyon A, Coughlin L, Ahmed S, et al. Susceptible bacteria can survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance. Cell Host & Microbe. 2024;32(3):396-410.e6. doi:10.1016/j.chom.2024.01.012

BibTeX
@article{Rodrigues2024,
  author = {Rodrigues, Marinelle and Sabaeifard, Parastoo and Yildiz, Muhammed Sadik and Lyon, Adam and Coughlin, Laura and Ahmed, Sara and Poulides, Nicole and Toprak, Ahmet C and Behrendt, Cassie and Wang, Xiaoyu and Monogue, Marguerite and Kim, Jiwoong and Gan, Shuheng and Zhan, Xiaowei and Filkins, Laura and Williams, Noelle S and Hooper, Lora V and Koh, Andrew Y and Toprak, Erdal},
  title = {Susceptible bacteria can survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance},
  journal = {Cell Host & Microbe},
  year = {2024},
  volume = {32},
  number = {3},
  pages = {396--410.e6},
  doi = {10.1016/j.chom.2024.01.012}
}
Kostenlos starten →